Category: Destination India
FDA Approves Mylan and Biocon’s Ogivri™, the First Biosimilar for Trastuzumab
UPDATE: Biocon/Mylan‘s breakthrough Herceptin biosimilar, Ogivri (MYL-1401O) received the US FDA approval for the treatment of HER2-positive breast cancer and ...
NIV Scientists Confirm New Dengue Virus in India
Dengue is one of the most serious diseases which risks health of the people in India every year. It is ...
Affordable Funding Options for Cancer Treatment in India
A person saves money throughout his life to fulfill many wishes for him and his family. An unfortunate incident of ...
6 Major Steps of Narendra Modi Government for Better Healthcare in India
India needs to go a long way in providing an easily accessible, efficient and cheap healthcare to every citizen. Despite ...
India’s Swagene Launched Personalized Medicine for Children with Blood Cancer
Swagene– the youngest molecular diagnosticians has brought forward the personalized medicine as the latest weapon of modern healthcare in India. The ...